Balance Sheet for Array BioPharma Inc. (ARRY)

$ 47.85 0.00 (0.00%) Volume: 0 4:00 PM EDT Jul 30, 2019
Statement: View:
Assets [+] in Thousands of Dollars
06/2018 06/2017 06/2016 06/2015 06/2014
Cash and Equivalents 114,748 125,933 56,598 55,691 68,591
Restrictable Cash - - - - -
Marketable Securities 297,739 108,390 53,344 122,635 42,407
Accounts Receivable 32,084 31,279 39,302 6,307 5,429
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 32,084 31,279 39,302 6,307 5,429
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 6,972 4,575 6,057 6,414 5,249
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 451,543 270,177 155,301 191,047 121,676
Land and Improvements - - - - -
Buildings and Improvement 18,105 17,434 15,577 15,335 32,171
Machinery, Furniture and Equipment 46,614 46,188 44,720 43,103 58,276
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 64,719 63,622 60,297 58,438 90,447
Gross Fixed Assets 64,719 63,622 60,297 58,438 90,447
Accumulated Depreciation (57,591) (55,490) (53,617) (53,388) (82,290)
Net Fixed Assets 7,128 8,132 6,680 5,050 8,157
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 774 104 6,323 1,614 6,152
Total Non-Current Assets 8,821 8,968 13,599 7,160 14,949
Total Assets 460,364 279,145 168,900 198,207 136,625
Liabilities [+] in Thousands of Dollars
06/2018 06/2017 06/2016 06/2015 06/2014
Accounts Payable 14,059 8,636 10,147 4,570 6,953
Short Term Debt 18,399 33,100 - - -
Notes Payable - - - - -
Accrued Expenses 33,721 32,963 20,208 20,116 11,484
Accrued Liabilities 33,721 32,963 20,208 20,116 11,484
Deferred Revenues 12,350 17,156 12,856 8,946 6,193
Current Deferred Income Taxes - - - - -
Other Current Liabilities 17,402 (22,304) 9,223 8,792 28,103
Total Current Liabilities 95,931 69,551 52,434 42,424 52,733
Long Term Debt 93,376 133,905 113,655 107,280 101,524
Deferred Income Tax 50,068 63,039 40,145 5,354 7,449
Other Non-Current Liabilities 51,314 63,962 40,743 5,850 8,089
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 144,690 197,867 154,398 113,130 109,613
Total Liabilities 240,621 267,418 206,832 155,554 162,346
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 219,743 11,727 (37,932) 42,653 (25,721)
Common Par 211 171 144 142 132
Additional Paid in Capital 1,286,000 930,293 763,324 751,073 652,696
Cumulative Translation Adjustments - - - - -
Retained Earnings (1,066,007) (918,661) (801,407) (708,567) (717,936)
Treasury Stock - - - - -
Other Equity Adjustments (461) (76) 7 5 2
Total Capitalization 313,119 145,632 75,723 149,933 75,803
Total Equity 219,743 11,727 (37,932) 42,653 (25,721)
Total Liabilities & Shareholder's Equity 460,364 279,145 168,900 198,207 136,625
Cash Flow (147,346) (116,818) (92,840) 9,369 (85,257)
Working Capital 355,612 200,626 102,867 148,623 68,943
Free Cash Flow (121,015) (42,874) (73,249) (8,300) (74,296)
Invested Capital 313,119 145,632 75,723 149,933 75,803
Shares Outstanding - Common Class Only 211,290 171,308 143,690 142,107 131,817
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 211,290 171,308 143,690 142,107 131,817
Total Common Shares Outstanding 211,290 171,308 143,690 142,107 131,817
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 198,490 163,207 142,964 136,679 123,403
Diluted Weighted Shares Outstanding 198,490 163,207 142,964 141,692 123,403